Relationship Of High CH50 Level And Interruption Of Cascade Reaction ...

Trang chủ » Fan C3 C4 Ch50 » Relationship Of High CH50 Level And Interruption Of Cascade Reaction ...

Có thể bạn quan tâm

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

In patients with pulmonary embolism (PE), forepart components of complements were activated. However there are interruption/decrease of cascade reaction and cytolytic effects in complement system. This study detected CRP, CH50, C3 and C4 levels in patients with venous thromboembolism (VTE) and compare with the imbalance of complement associated gene mRNA expression in PE patients. There was significant increase of CH50 in acute VTE patients. Even though CH50 increased significantly in acute VTE patients and had a relatively high sensitivity, cytolytic effects of complements might decrease, based on the genomics results of complement cascade reactions imbalance/interruption and increased total complements in VTE patients.

Keywords: CH50; complement; pulmonary embolism.

PubMed Disclaimer

Figures

Figure 1

Figure 1

A. Compared with normal range,…

Figure 1

A. Compared with normal range, CRP increased significantly in VTE patients. Density curve…

Figure 1 A. Compared with normal range, CRP increased significantly in VTE patients. Density curve of VTE patients was flatter and shifted to the right significantly (P < 0.01). B. Compared with normal range, CH50 increased and density curve shifted to the right significantly in VTE patients (P < 0.01). C. C3 was almost within the normal range and density curve shifted slightly to the left in VTE patients. D. C4 was almost within the normal range and density curve shifted slightly to the right in VTE patients.
See this image and copyright information in PMC

Similar articles

  • The complement and immunoglobulin levels in NMO patients. Chen Y, Li R, Wu AM, Shu YQ, Lu ZQ, Hu XQ. Chen Y, et al. Neurol Sci. 2014 Feb;35(2):215-20. doi: 10.1007/s10072-013-1481-y. Epub 2013 Jul 24. Neurol Sci. 2014. PMID: 23881468
  • Elevated levels of C3, C4, and CH50 of the complement system in ICU and non-ICU patients with COVID-19. Bagherimoghaddam A, Rafatpanah H, Mansouritorghabeh H. Bagherimoghaddam A, et al. Health Sci Rep. 2022 Feb 16;5(2):e519. doi: 10.1002/hsr2.519. eCollection 2022 Mar. Health Sci Rep. 2022. PMID: 35224220 Free PMC article.
  • Complement systems C4, C3 and CH50 not subject to a circadian rhythm. Lung T, Matozan K, Risch M, Sakem B, Nydegger UE, Risch L. Lung T, et al. Diagnosis (Berl). 2018 Jun 27;5(2):77-82. doi: 10.1515/dx-2018-0003. Diagnosis (Berl). 2018. PMID: 29813028
  • Effect of IFN-alpha on total haemolytic activity of CH50 complement system and C3, C4 levels in children with chronic hepatitis C. Woźniakowska-Gesicka T, Wiśniewska-Ligier M, Kupś J. Woźniakowska-Gesicka T, et al. Med Sci Monit. 2001 May;7 Suppl 1:202-6. Med Sci Monit. 2001. PMID: 12211720
  • Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review. Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E. Gómez-Outes A, et al. Vasc Health Risk Manag. 2014 Nov 7;10:627-39. doi: 10.2147/VHRM.S50543. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 25404858 Free PMC article. Review.
See all similar articles

References

    1. Cardiovascular Disease Educational and Research Trust; European Venous Forum; North American Thrombosis Forum; International Union of Angiology; Union Internationale du Phlebologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence) Int Angiol. 2006;25:101–161. - PubMed
    1. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:7s–47s. - PMC - PubMed
    1. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367:1075–1079. - PubMed
    1. Wang L, Gong Z, Liang A, Xie Y, Liu SL, Yu Z, Wang L, Wang Y. Compromised T-cell immunity and virus-like structure in a patient with pulmonary hypertension. Am J Respir Crit Care Med. 2010;182:434–435. - PubMed
    1. Wang L, Zhang X, Duan Q, Lv W, Gong Z, Xie Y, Liang A, Wang Y. Rod-like bacteria and recurrent venous thromboembolism. Am J Respir Crit Care Med. 2012;186:696. - PubMed
Show all 10 references

Related information

  • MedGen

LinkOut - more resources

  • Full Text Sources

    • Europe PubMed Central
    • PubMed Central

  • Research Materials

    • NCI CPTC Antibody Characterization Program

  • Miscellaneous

    • NCI CPTAC Assay Portal

Từ khóa » Fan C3 C4 Ch50